|
A phase I/II clinical trial of E6 T-cell receptor gene therapy for human papillomavirus (HPV)-associated epithelial cancers. |
|
|
Employment - MedImmune (I) |
Research Funding - Kite, a Gilead company (Inst) |
Patents, Royalties, Other Intellectual Property - Kite, a Gilead company; Lion Biotechnologies |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Kite, a Gilead company |
Stock and Other Ownership Interests - Kite, a Gilead company |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Kite, a Gilead company |
Patents, Royalties, Other Intellectual Property - NIH/NCI (Inst) |